In this episode of Edison Talks, Maxim Jacobs, Edison’s director of research for North America, has an in-depth discussion with Evan Jones, the CEO of OpGen. Topics include OpGen’s products and the company's focus on revolutionising the identification and treatment of bacterial infections, as well as the announced merger with Curetis.